| | Class 2 Device Recall Nova Biomedical |  |
| Date Initiated by Firm | March 30, 2004 |
| Date Posted | July 20, 2004 |
| Recall Status1 |
Terminated 3 on June 17, 2004 |
| Recall Number | Z-0827-04 |
| Recall Event ID |
28725 |
| Product Classification |
Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph - Product Code CHL
|
| Product | Stat Profile Critical Care Xpress CCX+ Analyzer
Catalog Number: 37413 |
| Code Information |
Domestic Serial Numbers: Y02C03170 Y02C03140 Y02C03180 Y02104060 Y02104180 Y02104070 Y02104210 Y02104080 Y02204180 International S/N: Y02204030 Y02204040 Y02204050 Y02204110 Y02204120 Y02204140 Y02204190 Y02304020 Y02C03190 Y02C03160 Y02C03090 Y02204060 Y02C03070 Y02304050 Y02C03050 Y02104090 Y02104230 Y02104170 Y02104020 Y02304070 |
| FEI Number |
1219029
|
Recalling Firm/ Manufacturer |
Nova Biomedical Corporation 200 Prospect St Waltham MA 02453-3457
|
| For Additional Information Contact | Paul MacDonald 781-647-3700 Ext. 211 |
Manufacturer Reason for Recall | Incorrectly assembled pumps may result in inconsistent compression of the tubing causing erratic results or calibration problems |
FDA Determined Cause 2 | Other |
| Action | Nova Biomedical notified users by telephone on 3/31/04 and conducted follow-up by letter either by email or fax. On-site visit will be scheduled to replace the pump assembly. |
| Quantity in Commerce | 30 units |
| Distribution | CA, IL, LA, MA ,NJ, NY, OH, PA, TX
International: Italy ,England, Japan,Turkey., U.A.E., Greece, Thailand, Switzerland, Finland, Saudi Arabia, Italy, Mexico, Trinidad, Ireland, France, Cyprus, Czech Republic, ,Germany |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|